tert-Butyl 4-(6-Nitropyridin-3-yl) piperazin-1-carboxylate CAS 571189-16-7 Pite > 98.0% (HPLC) Palbociclib Faktori Entèmedyè
Ruifu Chemical Supply Palbociclib Entèmedyè ki gen rapò:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butil 4-(6-Nitropyridin-3-yl) piperazin-1-carboxylate CAS 571189-16-7
tert-Butil 4-(6-Amino-3-Pyridyl) piperazin-1-carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentil-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-yon CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-yon CAS 1013916-37-4
Non Chimik | tert-butyl 4-(6-nitropyridin-3-yl) piperazin-1-carboxylate |
Sinonim | 1-Boc-4-(6-Nitro-3-Pyridyl) piperazin;4-(6-Nitro-3-piridinyl)-1-Piperazinecarboxylic Asid tert-Butil Ester;tert-Butil 4-(6-Nitro-3-Pyridinyl)-1-Piperazinecarboxylate |
Nimewo CAS | 571189-16-7 |
Nimewo CAT | RF-PI1850 |
Estati Stock | Nan Stock, Pwodiksyon Echèl Jiska Tòn |
Fòmil molekilè | C14H20N4O4 |
Pwa molekilè | 308.33 |
Mak | Ruifu Chimik |
Atik | Espesifikasyon |
Aparans | Limyè mawon poud mawon |
Pite / Metòd analiz | >98.0% (HPLC) |
LCMS | Ki konsistan avèk estrikti |
Pèt sou siye | <1.00% |
Enpurte total | <2.00% |
Tès Creole | Enterprise Standard |
Itilizasyon | Entèmedyè Palbociclib (CAS: 571190-30-2) |
Pake: Boutèy, sak papye aliminyòm, 25kg / tanbou katon, oswa selon kondisyon kliyan an
Kondisyon Depo:Sere nan resipyan ki fèmen nan yon kote ki fre ak sèk;Pwoteje kont limyè ak imidite
tert-Butyl 4-(6-nitropyridin-3-yl) piperazin-1-carboxylate (CAS: 571189-16-7) se yon entèmedyè nan Palbociclib (CAS: 571190-30-2).Palbociclib (ke yo rele tou nimewo konpoze PD-0332991) se yon dwòg eksperimantal pou tretman kansè nan tete ke Pfizer devlope.Li se yon inibitè selektif nan siklin-depandan kinas CDK4 ak CDK6.Palbociclib bloke pwogresyon sik selilè soti nan faz G1 nan S pa anpeche fosforilasyon CDK4/6-depandan retinoblastoma (RB).Palbociclib te itilize pou tretman HER2 negatif, reseptè estwojèn (ER) pozitif metastatik kansè nan tete.